What is CBGA and what does it do?

CBGA (Cannabigerolic Acid) is often called the "mother cannabinoid" or "stem cell" of cannabis because it serves as the precursor to all major cannabinoids including THC, CBD, and CBC. This non-psychoactive acidic compound is produced when olivetolic acid combines with geranyl pyrophosphate through the enzyme geranylpyrophosphate:olivetolate geranyltransferase. CBGA typically represents 1-2% of the total cannabinoid content in most cannabis strains, though some specialized cultivars have been bred to contain higher concentrations. Through enzymatic processes, CBGA converts to THCA, CBDA, and CBCA via specific synthase enzymes. When exposed to heat, light, or time, CBGA decarboxylates into CBG (cannabigerol). Preliminary research suggests CBGA may have several potential therapeutic properties, though clinical studies remain limited. Laboratory studies have indicated possible antibacterial, anti-inflammatory, and neuroprotective effects. Some research has explored CBGA's potential role in metabolic regulation and cardiovascular health, with one 2021 study suggesting it might help inhibit enzymes involved in carbohydrate absorption. CBGA has also shown promise in antiviral research. A 2022 Oregon State University study found that CBGA, along with CBDA, might bind to SARS-CoV-2 spike proteins, though this research was conducted in laboratory settings and requires further clinical validation. Commercially, CBGA is becoming increasingly valuable as extraction companies and cultivators recognize its importance. Some cannabis producers now specifically breed high-CBGA strains for extraction purposes, as controlling the conversion process allows for targeted cannabinoid production. **Disclaimer**: This information is for educational purposes only and should not be considered medical advice. The research on CBGA is still in early stages, and most studies have been conducted in laboratory or preclinical settings. Consult healthcare professionals for medical guidance regarding cannabis use.